Time-Restricted Feeding on Cardiovascular Health Effects
Launched by ZHENGQI QIU · May 14, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Subjects were able to provide signed and dated written informed consent.
- • Subjects are male undergraduates aged 18-24 years old.
- • BMI between 24 and 28.
- • Normal sleep duration, usually between 7-9 hours per day.
- • Stable sleep habits, typically going to bed around midnight (±1 hour).
- Exclusion Criteria:
- • Inability to comply with the time-limited diet plan.
- • Experiencing hypoglycemic reactions during the time-limited diet program.
- • Presence of metabolic diseases such as diabetes.
- • Participation in high-intensity physical training for more than 5 hours per week.
- • Extreme chronotypes, as indicated by scores ≤30 or ≥70 on the Morning and Evening Questionnaire Self-Assessment Scales (MEQ-SA).
- • Severe weight instability, defined as weight gain or loss of more than 5 kg in the 3 months prior to the study.
- • Severe food allergy or intolerance.
- • Participation in another medical study within 6 months prior to the first study visit.
About Zhengqi Qiu
Zhengqi Qiu is a dedicated clinical trial sponsor committed to advancing medical research and developing innovative therapies to improve patient outcomes. With a focus on rigorous scientific methodologies and ethical standards, Zhengqi Qiu oversees the design, implementation, and management of clinical trials across various therapeutic areas. By fostering collaborations with research institutions and healthcare professionals, the organization aims to generate robust data that supports regulatory approvals and enhances the understanding of complex medical conditions. Zhengqi Qiu's mission is to contribute to the future of healthcare through evidence-based research and a commitment to patient safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shenzhen, Guangdong, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0